Hydralazine is a direct-acting vasodilator that primarily targets the smooth muscle of peripheral resistance vessels, particularly arterioles rather than veins. By relaxing these blood vessels, it lowers total peripheral resistance and reduces arterial blood pressure. This drop in resistance triggers a reflex sympathetic stimulation of the heart, which can lead to increased heart rate and cardiac output. Midwives should understand that while blood pressure falls, the body's compensatory mechanisms attempt to maintain cardiac performance. In Nigerian obstetric practice, it remains a frontline agent for urgent blood pressure control, especially in secondary and tertiary health facilities where intravenous access and monitoring are readily available.
In obstetric emergencies, hydralazine is primarily indicated for the acute management of severe hypertension during pregnancy and the postpartum period. This typically means sustained systolic blood pressure readings of 160 mmHg or higher, or diastolic readings of 110 mmHg or higher, which put the mother at immediate risk of stroke or multi-organ failure. It is a cornerstone medication in the management protocols for preeclampsia and eclampsia. Midwives must recognize that hydralazine is used for acute crisis intervention rather than long-term maintenance therapy, as safer oral alternatives exist for chronic blood pressure control once stability is achieved.
Administering hydralazine requires strict adherence to institutional protocols to prevent precipitous drops in maternal blood pressure. It is typically given via slow intravenous bolus or continuous infusion when managing severe preeclampsia.
Continuous vigilance is mandatory when a parturient receives hydralazine. Midwives must monitor maternal blood pressure and pulse every 5 to 10 minutes immediately after administration until the pressure stabilizes, and then every 30 minutes. Urine output should be tracked closely using an indwelling catheter, aiming for at least 30 mL per hour to ensure adequate renal perfusion. Simultaneously, continuous or intermittent fetal heart rate monitoring is essential because a rapid fall in maternal blood pressure can cause fetal distress or uterine tachysystole. Any sign of late decelerations on the cardiotocograph warrants immediate medical notification and corrective maternal positioning.
While effective, hydralazine carries a profile of side effects that demands proactive midwifery care. Common maternal complaints include headache, flushing, palpitations, and dizziness resulting from vasodilation. Severe maternal hypotension can compromise uteroplacental blood flow. Midwives must educate patients on what to expect, manage complaints like headaches with approved analgesics if prescribed, and keep emergency resuscitation equipment and IV fluids nearby. Documenting the total dose, exact timing, and maternal-fetal responses remains a vital legal and clinical duty in every labor ward.